# Phase Ⅰ Study to Compare the Safety, Pharmacokinetic Profiles of CJ Amlodipine/Valsartan 10/160mg Tablet and Novartis Exforge 10/160mg Tablet

> **NCT01735890** · PHASE1 · COMPLETED · sponsor: **HK inno.N Corporation** · enrollment: 48 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** CJ Amlodipine/Valsartan 10/160mg Novartis Exforge 10/160mg

## Key facts

- **NCT ID:** NCT01735890
- **Lead sponsor:** HK inno.N Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-09
- **Primary completion:** 2012-11
- **Final completion:** 2012-11
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2013-09-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01735890

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01735890, "Phase Ⅰ Study to Compare the Safety, Pharmacokinetic Profiles of CJ Amlodipine/Valsartan 10/160mg Tablet and Novartis Exforge 10/160mg Tablet". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01735890. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*